Graminex - Products containing Flower Pollen Extract - Conservative Treatment of Benign Prostatic Hyperplasia (BPH) with Cernilton ® - Results of a Placebo-Controlled Double-Blind Study

Products Containing Flower Pollen Extract:

Pollen Aid
Prostanex
Graminex Flower
Pollen Extract

We are GMP
Certified

Conservative Treatment of Benign Prostatic Hyperplasia (BPH) with Cernilton ® - Results of a Placebo-Controlled Double-Blind Study

H. Becker, L. Ebeling

Introduction

In view of the changing age structure and the rising average life expectancy of the male population the phytotherapeutic treatment of benign prostatic hyperplasia (BPH) will become increasingly more relevant. The justification and the need for such a drug therapy can be estimated on the basis of the available epidemiological data: the cumulative probability for a 40-year-old man to be operated on for a BPH until the age of eighty is p = 0.292, and to develop clinical symptoms and/or signs is p=0.777. Consequently, for the treatment of BPH patients, a symptomatically oriented medication has priority. However, continuous observation of the course of the treatment rrvdst ensure that surgical measures are taken whenever they are indicated. Read the Full Study

© 1999 AB Cernelle · All rights reserved